Search research articles
Contact Us
Filters
Showing results (201-210 of 209) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 209 results.
Bioorganic & Medicinal Chemistry Letters
|
August 7, 2012
Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway
Ian Bruce, Mohammed Akhlaq, Graham C Bloomfield, et al.
Frontiers in Pharmacology
|
May 23, 2017
Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related Hydroxylases
Mike Petrassi, Rob Barber, Celine Be, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma
David A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters
|
September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"
David A Sandham, Lucy Barker, Lyndon Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 29, 2007
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists
David A Sandham, Clive Aldcroft, Urs Baettig, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 29, 2019
Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia
Christine Maric-Bilkan, Vikki M Abrahams, S Sonia Arteaga, et al.
Bioorganic & Medicinal Chemistry
|
September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases
David A Sandham, Nicola Arnold, Heinrich Aschauer, et al.
Histopathology
|
August 12, 2025
Composite gangliocytoma/neuroma and neuroendocrine tumour: a contemporary analysis of 71 cases shows risk factors for metastasis
Luiz M Nova-Camacho, Changqing Ma, Ibrahim Abukhiran, et al.
Journal of Medicinal Chemistry
|
May 24, 2021
Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
Darren Le Grand, Martin Gosling, Urs Baettig, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 209) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 209 results.
Bioorganic & Medicinal Chemistry Letters
|
August 7, 2012
Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway
Ian Bruce, Mohammed Akhlaq, Graham C Bloomfield, et al.
Frontiers in Pharmacology
|
May 23, 2017
Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related Hydroxylases
Mike Petrassi, Rob Barber, Celine Be, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma
David A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters
|
September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"
David A Sandham, Lucy Barker, Lyndon Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 29, 2007
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists
David A Sandham, Clive Aldcroft, Urs Baettig, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 29, 2019
Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia
Christine Maric-Bilkan, Vikki M Abrahams, S Sonia Arteaga, et al.
Bioorganic & Medicinal Chemistry
|
September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases
David A Sandham, Nicola Arnold, Heinrich Aschauer, et al.
Histopathology
|
August 12, 2025
Composite gangliocytoma/neuroma and neuroendocrine tumour: a contemporary analysis of 71 cases shows risk factors for metastasis
Luiz M Nova-Camacho, Changqing Ma, Ibrahim Abukhiran, et al.
Journal of Medicinal Chemistry
|
May 24, 2021
Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
Darren Le Grand, Martin Gosling, Urs Baettig, et al.
Page
of 21